Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
暂无分享,去创建一个
[1] H. Suryapranata,et al. Limitation of Infarct Size and Preservation of Left Ventricular Function After Primary Coronary Angioplast Compared With Intravenous Streptokinase in Acute Myocardial Infarction , 1994, Circulation.
[2] Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.
[3] Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.
[4] M. Simoons,et al. Effect of thrombolytic treatment delay on myocardial infarct size , 1992, The Lancet.
[5] J. Anderson,et al. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. , 1992, Journal of the American College of Cardiology.
[6] M. Beahrs,et al. Thrombolytic therapy for acute myocardial infarction. , 1991, Postgraduate medicine.
[7] M. Verstraete,et al. Value of electrocardiographic scoring systems for the assessment of thrombolytic therapy in acute myocardial infarction. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator. , 1991, European heart journal.
[8] R. Reneman,et al. Complete recovery in plasma of enzymes lost from the heart after permanent coronary artery occlusion in the dog. , 1990, Circulation.
[9] Very early thrombolytic therapy in suspected acute myocardial infarction. The Thrombolysis Early in Acute Heart Attack Trial Study Group. , 1990, The American journal of cardiology.
[10] F. Van de Werf,et al. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. , 1988, BMJ.
[11] J. Anderson,et al. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction. , 1988, American heart journal.
[12] G. Willems,et al. Myocardial enzyme depletion in infarcted human hearts: infarct size and equivalent tissue mass. , 1988, Cardiovascular research.
[13] Dwight E. Peake,et al. Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .
[14] M. Simoons,et al. Rapid enzyme release from acutely infarcted myocardium after early thrombolytic therapy: washout or reperfusion damage? , 1988, American heart journal.
[15] P. Serruys,et al. Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. , 1988, The American journal of cardiology.
[16] R. Nagai,et al. Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarction. , 1987, Circulation.
[17] R Roberts,et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.
[18] P. Serruys,et al. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? , 1986, Circulation.
[19] P. Serruys,et al. Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction. , 1986, American heart journal.
[20] P. Serruys,et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.
[21] E. Braunwald,et al. Myocardial reperfusion: a double-edged sword? , 1985, The Journal of clinical investigation.
[22] R. Ideker,et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. , 1984, Circulation.
[23] P. Rentrop,et al. Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: comparison with conventional treatment and correlation with infarct size. , 1984, Journal of the American College of Cardiology.
[24] R. Nohara,et al. Effects of coronary artery reperfusion on relation between creatine kinase-MB release and infarct size estimated by myocardial emission tomography with thallium-201 in man. , 1983, Journal of the American College of Cardiology.
[25] J. Coromilas,et al. Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion. , 1983, The New England journal of medicine.
[26] P. R. Frederick,et al. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. , 1983, The New England journal of medicine.
[27] P. Grande,et al. Estimation of Acute Myocardial Infarct Size in Man by Serum CK‐MB Measurements , 1982, Circulation.
[28] G. Willems,et al. Quantitative analysis of plasma enzyme levels based upon simultaneous determination of different enzymes. , 1982, Cardiovascular research.
[29] P. McHale,et al. Nonlinear Relationship Between Creatine Kinase Estimates and Histologic Extent of Infarction in Conscious Dogs: Effects of Regional Myocardial Blood Flow , 1980, Circulation.
[30] A. Van der Laarse,et al. The (iso)enzyme activities of lactate dehydrogenase, alpha-hydroxybutyrate dehydrogenase, creatine kinase and aspartate aminotransferase in human myocardial biopsies and autopsies. , 1980, Clinica chimica acta; international journal of clinical chemistry.
[31] A. Muijtjens,et al. Estimation of circulatory parameters in patients with acute myocardial infarction. Significance for calculation of enzymatic infarct size. , 1979, Cardiovascular research.
[32] S. Vatner,et al. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. , 1978, The Journal of clinical investigation.
[33] S. Effert,et al. Infarct Size Estimated from Serial Serum Creatine Phosphokinase in Relation to Left Ventricular Hemodynamics , 1977, Circulation.
[34] J. Jarmakani,et al. Effect of reperfusion on myocardial infarct, and the accuracy of estimating infarct size from serum creatine phosphokinase in the dog. , 1976, Cardiovascular research.
[35] Erhardt Lr. Clinical and pathological observations in different types of acute myocardial infarction. , 1974, Acta medica Scandinavica. Supplementum.
[36] L. Erhardt. Clinical and pathological observations in different types of acute myocardial infarction. , 1974, Acta medica Scandinavica. Supplementum.
[37] M. Nachlas,et al. A METHOD FOR THE QUANTITATION OF MYOCARDIAL INFARCTS AND THE RELATION OF SERUM ENZYME LEVELS TO INFARCT SIZE. , 1964, Surgery.
[38] A. Fletcher,et al. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. , 1959, The Journal of clinical investigation.
[39] A. Freiman,et al. Serum Activity Patterns of Glutamic Oxaloacetic Transaminase, Glutamic Pyruvic Transaminase and Lactic Dehydrogenase Following Graded Myocardial Infarction in Dogs , 1959, Circulation research.